Financhill
Back

Relay Therapeutics Vs. Iovance Biotherapeutics Industry Stock Comparison

Sell
15

RLAY
Relay Therapeutics

Last Price:
$4.17
Seasonality Move:
-14.64%
Sell
31

IOVA
Iovance Biotherapeutics

Last Price:
$7.38
Seasonality Move:
5.19%
Sell
15
Relay Therapeutics (RLAY) is a Sell

Is Relay Therapeutics a Buy, Sell or Hold?

  • The current Relay Therapeutics [RLAY] share price is $4.17. The Score for RLAY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • RLAY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
31
Iovance Biotherapeutics (IOVA) is a Sell

Is Iovance Biotherapeutics a Buy, Sell or Hold?

  • The current Iovance Biotherapeutics [IOVA] share price is $7.38. The Score for IOVA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • IOVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLAY Stock Price Chart

What is Relay Therapeutics's stock price today?

  • The Relay Therapeutics share price today is $4.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing selling pressure, which indicates risk of future bearish movement.

IOVA Stock Price Chart

What is Iovance Biotherapeutics's stock price today?

  • The Iovance Biotherapeutics share price today is $7.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IOVA is experiencing buying pressure, which is a positive indicator for future bullish movement.

RLAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 35.65 Sell
Chaikin Money Flow: -5188054 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.4 - 4.88) Sell
Bollinger Bands (100): (5.12 - 7.42) Sell

IOVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 32.93 Sell
Chaikin Money Flow: 6817787 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.79 - 9.03) Sell
Bollinger Bands (100): (8.45 - 10.93) Sell

RLAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.56 Sell
20-day SMA: 4.59 Sell
50-day SMA: 5.42 Sell
200-day SMA: 6.8 Sell
8-day EMA: 4.43 Sell
20-day EMA: 4.67 Sell
50-day EMA: 5.3 Sell
200-day EMA: 6.97 Sell

IOVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.74 Sell
20-day SMA: 8.46 Sell
50-day SMA: 9.4 Sell
200-day SMA: 10.28 Sell
8-day EMA: 7.72 Sell
20-day EMA: 8.29 Sell
50-day EMA: 9.01 Sell
200-day EMA: 9.51 Sell

Relay Therapeutics Earnings Growth & RLAY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.08 per share.

Iovance Biotherapeutics Earnings Growth & IOVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.48 per share.

Relay Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Iovance Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):